Hemochromatosis screening and awareness month | Clinical Trials
Hemochromatosis Screening And Awareness Month Hemochromatosis: the Silent Iron Overload Disorder Hemochromatosis, a hereditary disorder characterized by excessive iron absorption and accumulation in the body, often goes undiagnosed or misdiagnosed due to its subtle symptoms. By understanding hemochromatosis, individuals can recognize the warning signs and seek appropriate medical attention, potentially preventing serious complications associated with iron overload. Screening for Hemochromatosis:
BioPharma Nexus Conference
Cromos Pharma’s CEO to Present at the 17th BioPharma Nexus Conference Cromos Pharma’s CEO to present at the 17th BioPharma Nexus Conference, which is set to take place June 15-16, 2023 in Amsterdam, Netherlands.  Cromos Pharma’s CEO Vlad Bogin, MD, FACP will be participating as a speaker in the panel discussion “How to put Patients in the Heart of Clinical Trials & Daily Practice?”. Vlad is looking forward to meeting partners
Clinical Trials Protocol
Clinical Trial Success Starts with an Airtight Protocol A well-designed clinical trial protocol is paramount to ensuring the success of a clinical trial, and therefore, should be approached with utmost consideration. Protocols are more than just instruction manuals; they are multifunctional and detailed roadmaps that are the core mechanism for translating a brilliant idea into an effective clinical trial.  When writing a protocol, it is

TO FIND OUT MORE

INQUIRY@CROMOSPHARMA.COM